Synonyms: Azasan® | BW-57-322 | Imuran® | Jayempi®
azathioprine is an approved drug (FDA (1968), EMA (2021))
Compound class:
Synthetic organic
Comment: Azathioprine is an immunosuppressive antimetabolite. The active drug is believed to be mercaptopurine.
Marketed formulations may contain azathioprine sodium (PubChem CID 23678403). View more information in the IUPHAR Pharmacology Education Project: azathioprine |
|
Immunopharmacology Disease | |||
Disease | X-Refs | Comment | References |
Systemic lupus erythematosus |
Disease Ontology:
DOID:9074 OMIM: 152700 Orphanet: ORPHA536 |
Approved drug for SLE. | |
Rheumatoid arthritis |
Disease Ontology:
DOID:7148 OMIM: 180300 |
Approved drug for RA. | |
Crohn's disease |
Disease Ontology:
DOID:8778 OMIM: 266600 Orphanet: ORPHA206 |
Approved drug for CD. | |
Ulcerative colitis |
Disease Ontology:
DOID:8577 OMIM: 266600 Orphanet: ORPHA771 |
Approved drug for UC. |
Immunopaedia Case Studies Links |
Fireworks of autoimmunity from birth |
My eyes cross at twilight |